Quick Answer
Electromedical Technologies, Inc reported Total Revenue of $1.35 million for fiscal year 2023.
Electromedical Technologies, Inc — Key Financials by Year
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Total Revenue | $1.35M +17.3% |
$1.15M +26.7% |
$907.4K +23.0% |
$738.0K -11.1% |
$829.7K | — |
| Revenue (ASC 606) | $1.35M +17.3% |
$1.15M +26.7% |
$907.4K +23.0% |
$738.0K -11.1% |
$829.7K | — |
| Net Income | -$2.64M +23.9% |
-$3.47M +59.1% |
-$8.48M -119.0% |
-$3.87M -122.0% |
-$1.74M | — |
| Diluted EPS | $0.00 +100.0% |
-$0.03 +87.5% |
-$0.24 -20.0% |
-$0.20 | — | — |
| Total Assets | $748.4K -44.7% |
$1.35M -3.5% |
$1.40M -1.1% |
$1.42M +56.9% |
$902.9K | — |
| Cash and Equivalents | $87.7K -76.2% |
$368.4K -3.8% |
$383.2K +44.6% |
$264.9K | $0.00 | — |
| Stockholders Equity | -$2.87M -29.4% |
-$2.22M -207.4% |
-$722.5K +45.2% |
-$1.32M +39.6% |
-$2.18M -6.0% |
-$2.06M |
| Operating Income | -$2.06M -28.8% |
-$1.60M +57.8% |
-$3.80M -20.0% |
-$3.17M -89.8% |
-$1.67M | — |
| Gross Profit | $1.05M +17.7% |
$888.6K +25.5% |
$708.1K +30.3% |
$543.6K -8.1% |
$591.2K | — |
| Shares Outstanding | 463.29M +144.1% |
189.78M +116.3% |
87.73M +222.8% |
27.18M +51.8% |
17.90M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | June 30, 2024 | $237.6K | -19.4% | -18.1% |
| Revenue (ASC 606) | June 30, 2024 | $237.6K | -19.4% | -18.1% |
| Net Income | September 30, 2024 | -$724.6K | -92.4% | -413.4% |
| Diluted EPS | June 30, 2024 | $0.00 | — | +100.0% |
| Total Assets | September 30, 2024 | $568.8K | -33.3% | -14.5% |
| Cash and Equivalents | September 30, 2024 | $34.8K | -74.9% | -70.2% |
| Stockholders Equity | September 30, 2024 | -$4.00M | -59.2% | -17.8% |
| Operating Income | September 30, 2024 | -$381.0K | -59.4% | -51.3% |
| Gross Profit | September 30, 2024 | $30.6K | -87.8% | -82.3% |
| Shares Outstanding | September 30, 2024 | 725.35M | +53.8% | +28.1% |
- Electromedical Technologies, Inc reported Total Revenue of $1.35 million for fiscal year 2023.
- Electromedical Technologies, Inc showed an increase of +17.3% in Total Revenue compared to the prior fiscal year.
- Electromedical Technologies, Inc reported Revenue (ASC 606) of $1.35 million for fiscal year 2023.
- Electromedical Technologies, Inc showed an increase of +17.3% in Revenue (ASC 606) compared to the prior fiscal year.
- Electromedical Technologies, Inc reported Net Income of -$2.64 million for fiscal year 2023.
- Electromedical Technologies, Inc showed an increase of +23.9% in Net Income compared to the prior fiscal year.
- Electromedical Technologies, Inc reported Diluted EPS of $0.00 per share for fiscal year 2023.
- Electromedical Technologies, Inc showed an increase of +100.0% in Diluted EPS compared to the prior fiscal year.
- Electromedical Technologies, Inc reported Total Assets of $748.4 thousand for fiscal year 2023.
- Electromedical Technologies, Inc showed a decrease of -44.7% in Total Assets compared to the prior fiscal year.
- Electromedical Technologies, Inc reported Cash and Equivalents of $87.7 thousand for fiscal year 2023.
- Electromedical Technologies, Inc showed a decrease of -76.2% in Cash and Equivalents compared to the prior fiscal year.
- Electromedical Technologies, Inc reported Stockholders Equity of -$2.87 million for fiscal year 2023.
- Electromedical Technologies, Inc showed a decrease of -29.4% in Stockholders Equity compared to the prior fiscal year.
- Electromedical Technologies, Inc reported Operating Income of -$2.06 million for fiscal year 2023.
- Electromedical Technologies, Inc showed a decrease of -28.8% in Operating Income compared to the prior fiscal year.
- Electromedical Technologies, Inc reported Gross Profit of $1.05 million for fiscal year 2023.
- Electromedical Technologies, Inc showed an increase of +17.7% in Gross Profit compared to the prior fiscal year.
- Electromedical Technologies, Inc reported Shares Outstanding of 463.29 million shares for fiscal year 2023.
- Electromedical Technologies, Inc showed an increase of +144.1% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: